These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1516031)

  • 21. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
    Rempen A; Caffier H
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
    Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.
    Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E
    Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and natural history in lymph node-negative breast cancer patients.
    Arriagada R; Rutqvist LE; Skoog L; Johansson H; Kramar A
    Breast Cancer Res Treat; 1992; 21(2):101-9. PubMed ID: 1627813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
    Kaufmann M; Klinga K; Kühn W; Abel U
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Follow-up of 551 patients with node-negative breast cancer].
    Eidtmann H; Jonat W; Lange C; Friedrichs K; Maass H
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):454-61. PubMed ID: 1397940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer.
    Bolwell B; Andresen S; Pohlman B; Sobecks R; Goormastic M; Rybicki L; Bell K; Kalaycio M
    Bone Marrow Transplant; 2001 Apr; 27(8):843-6. PubMed ID: 11477442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear characteristics as indicators of prognosis in node negative breast cancer patients.
    le Doussal V; Tubiana-Hulin M; Hacene K; Friedman S; Brunet M
    Breast Cancer Res Treat; 1989 Nov; 14(2):207-16. PubMed ID: 2605347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of prognostic factors in breast cancer].
    Durand M
    Bull Cancer; 1984; 71(4):331-5. PubMed ID: 6498347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
    Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer.
    Clark GM; Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; McGuire WL
    Cancer; 1993 Mar; 71(6 Suppl):2157-62. PubMed ID: 8443766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of hormone receptors on the site of metastases in breast cancer].
    Stuller I; Zielinski CC; Aiginger P; Rausch P; Pötzi P; Kubista E; Salzer H; Sevelda P; Langer M; Staffen A
    Onkologie; 1987 Oct; 10(5):302-3. PubMed ID: 3317171
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
    Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.